The Texas Rangers Stadium Progresses As Season Winds Down

It may not be much right now, but this is what the early stages of a $1.1 billion stadium looks like. The Texas Rangers will be moving across the street in 2020, beginning play at their new home, Globe Life Field in Arlington, Texas.

The 1.7 million square-foot site broke ground on Sept. 28, 2017 and excavation of 97,000 truckloads of dirt was completed in March. The new park will include a retractable roof, an element that fans and players have been requesting for years. The team hopes that a climate-controlled environment will provide a better fan experience.

“The roof at Globe Life Field will be the first of its kind in baseball. With portions made of a transparent material, Rangers fans will enjoy outdoor ambience in air-conditioned comfort. The roof will retract in a matter of minutes, bringing the great outdoors to the ballpark experience,” the team announced.

At a question and answer session held by two Rangers vice-presidents recently, fans were told the roof will begin to be put together soon. The executives said they expect the roof will take 10 to 12 minutes to open and close and can make a 110-degree afternoon feel like 72 degrees.

The roof will also allow the park to hold more events year-round. The Rangers expect to host concerts, college sporting events and festivals, according to a press release. The executives said they, “think we will be able to compete in the concert business.” 

More recently, the accompanying ‘Texas Live’ project was completed between the existing Globe Life Park and yet-to-be-finished Globe Life Field. This entertainment and hospitality venue opened in August and is expected to bring more fans to Rangers games as well as make the area an attractive one outside of gamedays.

In September and October, construction will begin on the interior concourse and the stadium’s north plaza is expected to be completed.

For the latest news, videos, and podcasts in the AEC Industry, be sure to subscribe to our industry publication.
Follow us on social media for the latest updates in B2B!
Twitter – @AECMKSL

Follow us on social media for the latest updates in B2B!

Image

Latest

AI in marketing
From Queries to Conversations with AI in Marketing Analytics
April 21, 2025

In this episode of the SparkCast, Aby Varma—founder of Spark Novus, a firm that helps marketing leaders adopt AI responsibly and strategically—sits down with Daniel Kravtsov, CEO and Co-Founder of Improvado. Daniel shares his unique journey from Russia to founding a cutting-edge martech company in the Bay Area. Together, they explore how AI agents…

Read More
ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More